MA H 1125
in committeeAn Act relative to non-medical switching
Massachusetts · 2025-2026 Regular Session (194th General Court) · lower
Quick answers
Did MA H 1125 pass?
Not yet. MA H 1125 is in committee as of 2025-09-18 and has not come to a final vote. Latest recorded action (2025-09-18): Accompanied a new draft, see H4491
What is MA H 1125 about?
By Representative Day of Stoneham, a petition (accompanied by bill, House, No. 1125) of Michael S. Day relative to changes to health benefit plans that cause certain covered persons to switch to less costly alternate prescription drugs. Financial Services.
Who sponsors MA H 1125?
Michael S. Day is the primary sponsor of MA H 1125.
Description
By Representative Day of Stoneham, a petition (accompanied by bill, House, No. 1125) of Michael S. Day relative to changes to health benefit plans that cause certain covered persons to switch to less costly alternate prescription drugs. Financial Services.
- Introduced
- —
- Latest action
- 2025-09-18 — Accompanied a new draft, see H4491
- Bill type
- bill
- Last updated
- —
Sponsors
- Michael S. Dayprimary
Committees
Not provided by source.
Action timeline
2025-02-27
Referred to the committee on Financial Services
referral-committee
2025-02-27
Senate concurred
2025-06-03
Hearing scheduled for 06/10/2025 from 10:30 AM-01:00 PM in A-2
2025-09-18
Accompanied a new draft, see H4491
Versions
- Bill TextCompare
Documents
Votes
Not provided by source.
Related bills
- Replaces: HD 3340
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:56.590024Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=H 1125. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.